I would rather park my money in counters that give constant dividends rather than overvalued tech stocks. For tech stocks, US and HK market have better potentials than Msia. Malaysia stocks that have potential to outperform the market in the next few years would be healthcare, shipping and logistics. Covid is here to stay, that is the reality even with on going vaccinations.
Slowly coming, the Harta result is way above the market expectation. I mean who would expect +100% QoQ at this time. +20-30% maybe within expectation but 100% is fantastic. This will definitely build a strong base for Supermax price. With so many variants now threatening to overcome our only defense, the vaccine, glove demand will remain high for some time to come.
US new infection has shot up to more than 135,000 cases yesterday (Aug2) according to New York Times. Please note that data on worldometers.info is not accurate and updated.
US new infection has shot up to more than 135,000 cases yesterday (Aug2) according to New York Times. Please note that data on worldometers.info is not accurate and updated.
It looks like the June 's 60 % production durimg MCO did not impact both Harta and Kossan. Both. acheived record results due to high sales volume and higher ASP s.
Bear in mind Smax has been a top supplier to UK NHS for many years even prior to covid. Next tender closing on 31/8/2021 worth UK6B pounds
Source -The Guardian Wed 28 Jul 2021 18.00 BST The Department of Health and Social Care has set aside up to £6bn to spend on disposable gloves over the next two years, underlining the huge expense of continuing to supply the NHS with personal protective equipment.
The drive to secure PPE since the onset of the pandemic has led to rocketing prices, accusations of cronyism, and reports of forced labour being used to manufacture the products.
The independent National Audit Office found that the government had budgeted “an unprecedented £15bn of taxpayers’ money” for PPE during 2020-21, during a “chaotic” procurement process.
A “framework agreement”, quietly published by the government online on Friday, suggested that ensuring frontline workers never again go without critical protections is likely to be costly.
It states the value of the two-year contract for “medical examination gloves and surgical gloves” – which could be fulfilled by many different suppliers – is £6bn. DHSC sources said that figure was a cap, rather than a target, representing the maximum amount that could be spent over the lifetime of the contract.
But the fact that this extraordinary sum is being set aside points to the intense cost pressures the NHS continues to face. Pre-pandemic, the most recent contract for two years’ supply of gloves for the NHS – intended to cover 2020-22 – was worth £300m, a twentieth of the new tender.
About 65% of the world’s disposable gloves are produced in Malaysia, where there have been consistent reports of forced labour being used in factories.
The shadow trade secretary, Emily Thornberry, has written to the health secretary, Sajid Javid, urging him to ensure none of the £6bn is spent with suppliers who mistreat workers. In a letter seen by the Guardian, Thornberry said: “Throughout the pandemic, concerns have been raised over the alleged use of slave labour to make the hundreds of millions of gloves bought for our hospitals from Malaysia.
“Ministers have ignored repeated warnings and allegations against companies whose factories are still supplying the NHS today.
“Government controls have been exposed over the past two years as at best inadequate, and at worst nonexistent. If you are about to authorise £6bn in new spending on medical gloves over the next two years, surely now is finally the time to put proper controls alongside those contracts and ensure they are not going to suppliers in Malaysia that use slave labour.”
Labour is demanding that potential suppliers list the factories from which the gloves will be sourced, and demonstrate they have been independently audited to show they comply with international standards on slave labour. The tender closes on 31 August.
A government spokesperson said: “Proper due diligence is carried out for all government contracts and all suppliers appointed to our frameworks must comply with the Labour Standards Assurance System, which upholds robust rules to prevent abuses of labour.
“All our suppliers are required to follow the highest legal and ethical standards and if they fail to do so, they are removed from consideration for future contracts.”
The government was criticised last year for continuing to source gloves for the NHS from Top Glove, a Malaysian supplier previously accused of operating “slave-like conditions” in some of its factories. The firm has denied the allegations.
Meanwhile, ministers have faced consistent accusations of cronyism, with many lucrative contracts going to firms boasting close contacts to senior government figures, including the former landlord of Matt Hancock’s local pub, The Cock, who denied profiting from the personal contact.
Government insiders said the publication of the formal tender – likely to be followed by others for critical products – marks the return of a more systematic approach to procurement. But it also signals that the impact of the pandemic on NHS costs is likely to continue. The NHS was given more than £60bn in extra funding in 2020-21 to cope with the pandemic, taking its total budget to more than £212bn.
But some Whitehall officials expect Javid to have to bid for another funding boost before the year is out, as the health service struggles with the backlog in other cases created when the NHS was focused on treating Covid patients. A report produced for the government last year on the sector suggested the global market for PPE had ballooned by 300-400% as the pandemic hit, driven partly by its widespread use in settings such as workplaces.
hey MM you dont talk cock here ok...every day negative and rubbish comment ..what do you benefit by being very negative when the fundamental and price now is value buy..pls for goodness sake.
Looks like the shortists may have over invested in their shorting business, so now they ngeh ngeh must maintain their target to bring down the glove prices to make their money. I really wonder if they have made a huge mistake or not? Covid is still thriving and gaining traction everywhere. Maybe shortists should wake up to the reality.
i think got 1 reason but only my personal thinking. nowadays, not many company can give generous dividend like the old days except for GLOVES. All the local institute may have suffering lower income and maybe will effect a little bit of their portfolio perfomance. Thats why, they keep pressing the price of gloves so that they can grab more shares as they can ,so they can enjoy more dividend income just like the old days from TENAGA, MAYBANK,PUBLIC BANK.
only my 2 cents for sharing. dont scold me. welcome all the discussion.
Lamstilllearning So in the end those retail investors who bought high and sell low are the losers. Nevertheless, knowing when to enter and when to exit is the trick of this money game. But it is easier said than done. Financial institutions are always the winners. Seeing every year the banks made huge profits we will understand why. My 2 cents too.
@Citadel9999 toonefa hide again??? where limit up???? 03/08/2021 4:48 PM
Haha Hindside-Seikau, u really got a bone to pick with me ya. U drunk again today ka? pls scroll back and tell me where I got say today limit up? Stop mixing drugs and alcohol, u may suddenly wake up in Holland.
Looking at Top Glove Corp Bhd's earnings forecasts, for example, analysts are expecting the world's largest rubber glove maker to post a net profit of RM8.91 billion for its financial year 2021 (FY21) ending Aug 31, 2021 according to Bloomberg data. This would be a 376% year-on-year (y-o-y) jump from RM1.87 billion the year before.
Similarly, Hartalega Holdings Bhd is expected to post RM3.89 billion for its FY22 ending March 31, 2022 (up 35% y-o-y), Kossan Rubber Industries Bhd to report RM3.3 billion for its FY21 ending Dec 31, 2021 (up 203% y-o-y), while Supermax Corp Bhd is seen to post a net profit of RM3.7 billion for its FY21 ended June 30, 2021 (up 602% y-o-y). -----------------------------------------------
For Harta , anal-lease expect FY22 PAT to be 3.89b But 1Q22 = 2,262,265 So for next 3 Qtrs they expect PAT of 1.63b ??? Is that logical? Next 3 qtrs = 0.54b/ qtr? I think by 2Q22, Harta will exceed their estimate of FY22 alrdy. What u think pjseow? So, this show Harta result today is grossly beyond their expectation.
For Supermax, anal-lease expect FY21 = 3.7b Up to 3Q21 , Supermax PAT = 2.9b So they expect 4Q21 to be 800mil. I think they will be surprised again . Anyway this means MM have to prepare for the massacre of his little weenie.
I think they didn't foresaw that Delta will change the glove demand landscape so fast. And then later Epsilon will wreck more havoc bcos its as transmissible as Delta but has totally evade all the vaccines. #Supermax from Holland to Bulan
Hey Stealth, no worries coz there is good support for Supermax price. Just gotta wait for shortists to realize that they are on the wrong direction. They need to U-turn soon.
Agree Stealth, but if they keep on short selling but ppl only buy buy and not sell to them then they will keep losing money. This will happen if Delta and Epsilon later cause huge demand for gloves and all glovemakers making huge profits for the next 8 qtrs and give attractive dividend every quarter, then nobody want to sell their shares anymore. So, it doesnt make sense for shortists to keep on shorting against the reality of things. They will have to make U turn to quickly to buy up many shares at low price to cover back side before ppl decide to hold for longer term.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
wbwanabe
224 posts
Posted by wbwanabe > 2021-08-03 15:03 | Report Abuse
I would rather park my money in counters that give constant dividends rather than overvalued tech stocks. For tech stocks, US and HK market have better potentials than Msia. Malaysia stocks that have potential to outperform the market in the next few years would be healthcare, shipping and logistics. Covid is here to stay, that is the reality even with on going vaccinations.